Asociacion Espanola De Genetica Humana (AEGH) 2026
This congress, already established as a benchmark for interdisciplinarity in genetics, will once again bring together professionals from multiple areas related to human genetics, with the aim of fostering scientific dialogue, innovation and collaboration around the current and future challenges of the field.
Oxford Nanopore will be exhibiting at AEGH 2026.
We will also host a presentation; "Ask more of your sequencing".
Speakers, presentation details and registration below. Please register to save your seat.
Please also visit us at Booth 41 - 42.
Agenda
Agenda (subject to change) | ||
|---|---|---|
A single assay, multiple perspectives: improving the understanding of genetic diseases and cancer | Cristina Gamba, Associate Director of Product Marketing, Software and Informatics | Oxford Nanopore Technologies |
AI-assisted genome analysis with Nanopore sequencing | Dr Stephan Ossowski | Tuebingen |
Bridging the Gap: Clinical Utility of Nanopore Sequencing in Constitutional and Cancer Genetics. | Dr Mathilde Filser | Gustave Roussy |
Speakers
In oncogenetics, identifying genetic predispositions within families with evocative personal or family histories of early-onset or multiple cancers is paramount. Such identification directly impacts immediate patient care and dictates the screening and follow-up strategies for relatives. Identifying the underlying genetic aberration is therefore essential. While the democratization of short-read gene panels has significantly advanced this field, a subset of cases remains molecularly unresolved.
In oncogenetics, identifying genetic predispositions within families with evocative personal or family histories of early-onset or multiple cancers is paramount. Such identification directly impacts immediate patient care and dictates the screening and follow-up strategies for relatives. Identifying the underlying genetic aberration is therefore essential. While the democratization of short-read gene panels has significantly advanced this field, a subset of cases remains molecularly unresolved.
Mathilde Filser, Healthcare professional, Gustave Roussy
Stephan Ossowski, Professor Institute of Medical Genetics and Applied Genomics, University of Tubingen
